Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327725 · ClinicalTrials.gov registry record · NA
Fatigue Reduction Diet in Lymphoma Survivors
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05327725 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 10 participants.
The verdict
NCT05327725, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this small preliminary study is to gather preliminary data to support a large randomized controlled trial of a fatigue reduction diet intervention among diffuse-large B-cell lymphoma (DLBCL) survivors. This study will provide nutritional counseling to 10 adult patients (18 years or older) with DLBCL who have completed their upfront chemotherapy treatment and remained in remission for 2 years prior to enrollment. The study will employ individualized dietary counseling, provided by a registered dietitian (RD), by phone or video teleconferencing in 8 sessions over 3 months. Dietary intake and fatigue will be assessed at baseline and 3 months. The objective of the study is to determine feasibility of the intervention and adherence to the fatigue reduction diet. Data obtained from this preliminary study would be used to support a well-powered future randomized trial of FRD vs regular diet in survivors of DLBCL.
Interventions
- OTHER Fatigue Reduction Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2021-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05327725
The ClinicalTrials.gov registry entry for NCT05327725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fatigue Reduction Diet is the first listed.
NCT05327725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05327725 about?
NCT05327725 is a clinical study titled "Fatigue Reduction Diet in Lymphoma Survivors". The purpose of this small preliminary study is to gather preliminary data to support a large randomized controlled trial of a fatigue reduction diet intervention among diffuse-large B-cell lymphoma (DLBCL) survivors. This study will provide nutritional counseling to 10 adult patients (18 years or ol...
What is the current status of trial NCT05327725?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-03-15. Estimated completion is 2021-09-24.
What interventions are being tested in trial NCT05327725?
The interventions under investigation include: Fatigue Reduction Diet (OTHER).
Who is sponsoring clinical trial NCT05327725?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.